Supplementary Materials and Methods

RT-PCR and qRT-PCR:
mRNA was extracted using the AllPrep DNA/RNA/Protein Mini Kit (Qiagen) and cDNA transcribed with the Transcription First Strand cDNA Synthesis Kit (Roche) according to the manufacturer's description. RT-PCR was carried out according to the manufacturer's descriptions using the HotStarTaq PLUS DNA Polymerase kit (Qiagen) with the following primers (ASTN2: forward, 5'-TACTGGTGCTCCAGGGAAAGG, reverse, 5'-CCCAATAGCTGGCTGAACAT, β-ACTIN: forward, 5'-AAACTGGAACGGTGAAGGTG, reverse, 5'-AGAGAAGTGGGGTGGCTTTT). qRT-PCR was performed with TaqMan primer/probe sets (ASTN2 TaqMan gene expression assay (#Hs01024740_m1) which detects exon boundary 18-19, Human GUSB (Beta Glucuronidase) Endogenous Control (#4333767T, Applied Biosystems) and TaqMan Fast Advanced Master Mix, all according to the manufacturers' descriptions on a Roche LightCycler 480 (Roche).
Primary cell and cell line culture:
PBMCs from human subjects were isolated using BD Vacutainer™ CPT™ Tubes (BD Biosciences #362753). 10 x 10^6 cells were first plated in T cell medium (RPMI-1640, 10% FBS, 2 mM Glutamine, 100 U/ml Penicillin/Streptomycin, 10 µM HEPES) for 3 hrs, allowing monocytes to attach to the plate and be discarded. CD4+ cells were then sorted by MACS Separation using CD4 MicroBeads (human) and MS columns (Miltenyi Biotec) according to the manufacturer's descriptions and expanded in T cell medium containing 30 U/ml IL2 (Peprotech #200-02) and CD3/CD28 beads (Dynabeads #11161D) according to the manufacturer's description. Media change (T cell medium containing IL2) was performed every two days and cells were collected at DIV 8 for mRNA and protein analysis.
Immunohisto/cytochemistry: Briefly, vibratome sections were blocked with 15% normal horse serum (Gibco), 0.1% saponin in PBS overnight and then incubated with primary antibodies overnight at 4°C and with Alexa Fluor® secondary antibodies for 2 hours to overnight at room temperature and 4°C respectively. In vitro cultured cells were blocked in 1% normal horse serum, 0.05% Triton, incubated in primary antibodies overnight at 4°C followed by secondary Alexa Fluor® antibodies for 1 hour at room temperature. Sections/cells were mounted with ProLong® Gold anti-fade mounting media and sections were covered with 1.5 thickness Fisherbrand cover glass.
Antibodies used for immunohistochemistry, immunoprecipitation and Western blot:
Primary antibodies, Rabbit: anti-ASTN2 (1:1000-2000 on sections, and 1:500 on cells, 1:200 for Western Blot (1), anti-Calbindin D28-k (1:500, Swant #CB38), anti-GFP (1:500, Invitrogen #A11122). Mouse: anti-Calbindin (1:500, Swant #300), anti-Flag (1:1000, Sigma #1804), anti-HA (1:500, Roche #1 583 816 001), anti-cMYC (1:50, Calbiochem #OP10), anti-AP-2 (1:250, BD Transduction Laboratories #611350), anti-NLG2 (1:100, Synaptic Systems #129 511), anti-GAPDH (1:10,000, Chemicon #mab374) anti-ROCK2 (1:1000, BD Transduction Laboratories #610623), anti-Rab4 (1:100, BD Transduction Laboratories #610888), anti-Rab5 (1:200, Synaptic Systems #108011), anti-Rab7 (1:100, Santa Cruz #sc-376362). Goat: anti-GluD2 (1:100, Santa Cruz #sc-26118). Secondary antibodies: Donkey anti-mouse, -rabbit, and -goat IgG conjugated to Alexa 405 (abcam), 555, 633, and 647 (Molecular Probes), all used at 1:300. HRP-conjugated secondary antibodies (Jackson Immunoresearch) were used at 1:8000 (anti-mouse, # 515-035-062) or 1:3000 (anti-rabbit #111-035-144) for Western blots.
cDNA/ShRNA constructs: The following plasmids were used: pGIPZ lentiviral plasmids containing Astn2 shRNA (# V3LMM440320) and scramble shRNA (Thermo Scientific Open Biosystems), OLFM1-MYC-Flag (Origene #MR207779), AP2s-MYC-Flag (Origene #MR200768), Clqc-MYCFlag (Origene #MR203092), pCAG:GPI-GFP (Addgene #32601), pMES-SLC12a5-HA (2), pNice-NLGN1-CFP, pNice-NLGN2-CFP, pNice-NLGN3-YFP, pNice-NLGN4-YFP (3, 4), pNice-NLGN1-HA-YFP (gift from Dr Peter Scheiffele), pCdh2-CFP (Cdh2 cDNA gift from Dr. Richard Huganir, 5), pRK5-MYC and pMSCXβ-Venus-α-tubulin (used for flow cytometry control) were provided by Dr David Solecki. ASTN2 and JDUP containing constructs were created as follows: the sequence between the XbaI/BamHI sites of the pFU-cMVIIA-PE lentiviral plasmid (6) was removed including the DsRed/LoxP sequences. The full length Astn2 mouse cDNA was amplified from previously reported plasmids (1) and modified to include the 5' region of the gene, using a 5' primer with an XbaI restriction site and a 3' primer with a BamHI site. This sequence (full length ASTN2 splice variant 201, www.ensemble.org) was inserted in frame into the pFU backbone at XbaI/BamHI, creating pFU-Astn2-EGFP. To create the conditional construct, pFU-cAstn2-EGFP, a LoxP-dsRED-LoxP sequence (synthesized as a gblock fragment by Integrated DNA Technologies, IDT) was inserted into the XbaI site, upstream of the Astn2 sequence. pFU-cJDUP-EGFP was created by excising the sequence between the BsiW1/BlpI sites of pFU-cAstn2-EGFP and replacing it with a synthesized sequence representing a FNIII domain deleted version (gblock, IDT). The nonconditional version (pFU-JDUP-EGFP) was created by excising the LoxP-DsRED-LoxP sequence in pFU-cJDUP-EGFP with XbaI and re-ligating the plasmid. ASTN2-HA-FLAG and JDUP-HA-FLAG plasmids were made by replacing the EGFP sequence in pFU-ASTN2-EGFP and pFU-JDUP-EGFP with in-frame HA-FLAG sequences.
Flow cytometry: Transfected HEK 293T cells were harvested in 1 mM EDTA in PBS. The surface fraction of YFP-linked surface proteins was immuno-labeled (live) with rabbit anti-GFP followed by Alexa-647 anti-rabbit and cells were stained with Propidium Iodide (Sigma-Aldrich) for dead cell exclusion. Flow cytometry analysis (BD Accuri C6, BD Biosciences) was carried out using the 488 nm and 640 nm lasers and the CFlow Sampler software (BD Biosciences). A total of 20,000 single viable cells, identified by size and lack of Propidium Iodide staining, were analyzed per condition (resulted in approximately 100,000 events per condition). Gates were set using nontransfected control cells and cells expressing cytosolic GFP (α-tubulin-GFP), which were processed for live GFP labeling as described above. Data were analyzed by FlowJo v.9.3.3 (TreeStar Inc., Ashland, OR).
Knockdown of ASTN2 in HEK cells and neurons:
HEK cells were transfected using Lipofectamine 2000, with plasmids expressing the Astn2 cDNA alone or together with shRNA and scrambled constructs. Two days later, cells were processed for immunohistochemistry and Western blot as described earlier. For knockdown in neurons, mixed cerebellar neurons isolated at P7 were nucleofected (Amaxa Nucleofector II) with shRNA or scrambled constructs using the mouse neuron nucleofector kit (Lonza) according to the manufacturer's description. Cells were cultured as described previously for six days and then processed for Western blot. In a second experiment, GFP+ cells indicative of shRNA construct expression were sorted (BD FACSAria) from GFPnegative cells and then processed for Western blot.
Imaging: Images were acquired using an inverted Zeiss LSM 880 NLO laser scanning confocal microscope with a Plan-Apochromat 40x/1.4 NA objective oil immersion lens and 2.8 x digital zoom. For the lower power image in Fig. 2a a Plan-Apochromat 10x/0.45 NA lens was used. Images were acquired by setting the same gain and offset thresholds for all images per experiment and over/underexposure of signal was avoided. Images were quantified in ImageJ (version 2.0.0-rc-38/1.50b) unless stated otherwise. https://decipher.sanger.ac.uk). ASTN2 CNVs fall above the median for ID, ASTN1 is the highest scoring for ID, while ASTN2 but not ASTN1 is among the highest for enrichment in speech and language delay, excluding the classical speech and language genes FOXP2 and CNTNAP2 (12). 
Fig S2
